SERUM LIPID PROFILE AND ITS ASSOCIATION WITH HYPERTENSION IN INDIA – A CROSS-SECTIONAL STUDY

Main Article Content

Dr. Sudhindra D.
Dr. Ujwala N. Jagdale
Dr. Babu Sunil Kiran K.L.
Dr. Naveen Poojar C.M.

Keywords

Hypertension; Lipid profile; Dyslipidaemia; LDL-cholesterol; Triglycerides; Indian adults; Community screening.

Abstract

Background


Hypertension is widely encountered in Indian outpatient practice, often appearing alongside other metabolic disturbances that go unnoticed for several years. Lipid abnormalities are among the most frequent of these accompanying changes, yet their relationship with hypertension in community settings is not always clear, especially when individuals seek care irregularly or undergo testing only during screening drives.


Objective


To examine how fasting lipid parameters vary between hypertensive and normotensive adults in an Indian community sample, and to explore whether specific lipid markers show stronger associations with elevated blood pressure.


Methods


This cross-sectional study included 260 adults recruited from community screening camps and routine outpatient visits. Blood pressure was measured using standard procedures, and hypertension was defined as systolic ≥140 mmHg or diastolic ≥90 mmHg. Fasting lipid profiles were obtained through enzymatic assays. Associations between lipid markers and hypertension were analysed using t-tests, chi-square tests, and subgroup comparisons across age, sex, and BMI.


Results


Hypertension was present in a little over one-third of participants. Mean total cholesterol, LDL-cholesterol, and triglyceride levels were noticeably higher among hypertensive adults, while HDL-cholesterol tended to be lower. These differences were most apparent in middle-aged and overweight groups. The proportion of participants with dyslipidaemia was also significantly higher in the hypertensive category (p<0.001). LDL-cholesterol showed the strongest association with hypertension, followed by triglycerides.


 


 


Conclusion


In this community sample, lipid abnormalities were more frequent and more pronounced among adults with hypertension. The pattern suggests a shared metabolic pathway that may begin earlier than overt disease. Incorporating routine lipid assessment into community blood pressure screening may help identify individuals at higher cardiometabolic risk in India.

Abstract 0 | PDF Downloads 0

References

[1] Gupta R, Xavier D. Hypertension: The most important non communicable disease risk factor in India. Indian Heart J 2018;70(4):565–72.
[2] Gordon T, Castelli WP, Hjortland MC, et al. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 1977;62(5):707–14.
[3] Joshi SR, Anjana RM, Deepa M, et al. Prevalence of dyslipidemia in urban and rural India: The ICMR–INDIAB Study. PLoS One 2014;9(5):e96808.
[4] Chaturvedi V, Ramakrishnan L, Gupta N, et al. Blood pressure and hypertension epidemiology in India: An analysis from the National Family Health Survey-5. J Hum Hypertens 2022;36(5):434–42.
[5] Gupta R, Gaur K, Ram CVS. Emerging trends in hypertension epidemiology in India. J Hum Hypertens 2019;33(8):575–87.
[6] Stamler J, Wentworth D, Neaton JD. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees. JAMA 1986;256(20):2823–8.
[7] Tall AR, Rader DJ. The trials and tribulations of CETP inhibitors. Circ Res. 2018;122(1):106–12.
[8] Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC multi society cholesterol guideline. J Am Coll Cardiol 2019;73(24):e285–350.
[9] Anchala R, Kannuri NK, Pant H, et al. Hypertension in India: A systematic review and meta-analysis of prevalence, awareness, and control. J Hypertens 2014;32(6):1170-7.
[10] Zanchetti A, Thomopoulos C, Parati G. Randomized controlled trials of combined lipid and blood pressure treatment: Evidence and implications. Eur Heart J 2015;36(6):365-75.
[11] Mendis S, Puska P, Norrving B, eds. Global atlas on cardiovascular disease prevention and control. Geneva: World Health Organization 2011.